Hemogenyx Pharmaceuticals (LSE:HEMO) Price-to-Tangible-Book : 7.58 (As of May. 22, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Hemogenyx Pharmaceuticals Price-to-Tangible-Book?

As of today (2024-05-22), Hemogenyx Pharmaceuticals's share price is £0.01515. Hemogenyx Pharmaceuticals's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was £0.00. Hence, Hemogenyx Pharmaceuticals's Price to Tangible Book Ratio of today is 7.58.

The historical rank and industry rank for Hemogenyx Pharmaceuticals's Price-to-Tangible-Book or its related term are showing as below:

During the past 9 years, Hemogenyx Pharmaceuticals's highest Price to Tangible Book Ratio was 96.50. The lowest was 2.34. And the median was 10.50.

LSE:HEMO's Price-to-Tangible-Book is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.85
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Hemogenyx Pharmaceuticals's share price is £0.01515. Hemogenyx Pharmaceuticals's Book Value per Sharefor the quarter that ended in Dec. 2023 was £0.00. Hence, Hemogenyx Pharmaceuticals's P/B Ratio of today is 7.58.

Hemogenyx Pharmaceuticals Price-to-Tangible-Book Historical Data

The historical data trend for Hemogenyx Pharmaceuticals's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hemogenyx Pharmaceuticals Price-to-Tangible-Book Chart

Hemogenyx Pharmaceuticals Annual Data

Trend

Feb15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

96.50

2.34

4.42

11.50

Hemogenyx Pharmaceuticals Semi-Annual Data
	Feb15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial												2.34	1.86	4.42	5.10	11.50

Competitive Comparison of Hemogenyx Pharmaceuticals's Price-to-Tangible-Book

For the Biotechnology subindustry, Hemogenyx Pharmaceuticals's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hemogenyx Pharmaceuticals's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hemogenyx Pharmaceuticals's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Hemogenyx Pharmaceuticals's Price-to-Tangible-Book falls into.

Hemogenyx Pharmaceuticals Price-to-Tangible-Book Calculation

Hemogenyx Pharmaceuticals's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	0.01515	/	0.002
	=	7.58

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Hemogenyx Pharmaceuticals Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Hemogenyx Pharmaceuticals's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Hemogenyx Pharmaceuticals (LSE:HEMO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hemogenyx Pharmaceuticals PLC (LSE:HEMO) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

5HU:Germany

Address

60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR

Website

https://www.hemogenyx.com

Hemogenyx Pharmaceuticals PLC is a operator of a biotechnology company intended to focus on the discovery, development, and commercialization of novel therapies and treatments for blood diseases, like leukaemia and lymphoma. The company's technologies aim to change the way in which bone marrow/hematopoietic stem cell transplants are performed and improve their efficacy, its three distinct products include an immunotherapy product for the treatment of relapsed/refractory acute myeloid leukaemia (AML) and patient conditioning, the bi-specific antibody, for the treatment of AML and a community-based rehabilitation / Biomedical engineering platform, enabling users to generate treatments for existing and emerging viral infections.

Hemogenyx Pharmaceuticals (LSE:HEMO) Headlines

No Headlines